Walleye Capital
EDIT icon

Walleye Capital’s Editas Medicine EDIT Stock Holding History

Walleye Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,100
Closed -$98.6K – 4543
2025
Q4 		$98.6K Buy
48,100
+21,600
+82% +$62.4K ﹤0.01% 3874
2025
Q3 		$92K Buy
+26,500
New +$74K ﹤0.01% 3744
2025
Q1 		– Sell
-16,700
Closed -$21.2K – 4451
2024
Q4 		$21.2K Sell
16,700
-31,000
-65% -$79K ﹤0.01% 4493
2024
Q3 		$163K Buy
47,700
+41,700
+695% +$182K ﹤0.01% 4141
2024
Q2 		$28K Buy
6,000
+5,700
+1,900% +$32.2K ﹤0.01% 5060
2024
Q1 		$2.23K Buy
+300
New +$2.49K ﹤0.01% 5254
2023
Q2 		– Sell
-37,200
Closed -$270K – 4441
2023
Q1 		$270K Sell
37,200
-300
-0.8% -$2.67K ﹤0.01% 2211
2022
Q4 		$333K Buy
37,500
+28,800
+331% +$316K 0.01% 1715
2022
Q3 		$106K Buy
+8,700
New +$136K ﹤0.01% 2398
2020
Q2 		– Sell
-6,000
Closed -$119K – 699
2020
Q1 		$119K Sell
6,000
-17,200
-74% -$434K 0.03% 561
2019
Q4 		$687K Buy
23,200
+500
+2% +$12.5K 0.04% 545
2019
Q3 		$516K Buy
22,700
+9,100
+67% +$225K 0.03% 736
2019
Q2 		$336K Buy
13,600
+7,100
+109% +$169K 0.04% 682
2019
Q1 		$159K Buy
+6,500
New +$147K 0.03% 861

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Walleye Capital's EDIT Position: Q2 2026 in Review

Walleye Capital opened a new position in Editas Medicine (EDIT) in Q2 2026: 183,859 shares worth $596K. The stake represents ﹤0.01% of the portfolio and ranks #2564 among its holdings. This is a return to the name: Walleye Capital previously reported a position in EDIT as recently as Q4 2025.

Walleye Capital first reported a position in EDIT in Q1 2019 and has held it in 13 quarters since. The position peaked at $1.38M in Q3 2022. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Walleye Capital held 183,859 shares of Editas Medicine worth $596K as of Q2 2026.
  • Editas Medicine was a new Walleye Capital position in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2564 holding.
  • Walleye Capital first reported a position in Editas Medicine in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Editas Medicine position peaked at $1.38M in Q3 2022.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.